An interventional study of Electromagnetic stimulation therapy (BIOCON-2000) and Electromagnetic stimulation therapy with biofeedback in Urinary Stress Incontinence, sponsored by Samsung Medical Center. Completed at 1 site in Korea, Republic of. Open to female participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2019-12-02.
Sponsored by Samsung Medical Center · Not applicable, Interventional, and Treatment
The aim of this study is to compare the efficacy between Electromagnetic Stimulation therapy and Electromagnetic Stimulation therapy with Extracorporeal Biofeedback in Stress Urinary Incontinence patient.
658 studies on the registry are indexed under Urinary Incontinence, Stress; 123 are open to participants now.
This study's enrollment of 66 is close to the median of 70 across 509 interventional studies indexed under Urinary Incontinence, Stress.
Browse Urinary Incontinence, Stress studies →Samsung Medical Center is the lead sponsor of 980 studies on the registry; 146 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Electromagnetic stimulation therapy group
Device: Electromagnetic stimulation therapy (BIOCON-2000)
Electromagnetic stimulation therapy with biofeedback group
Device: Electromagnetic stimulation therapy with biofeedback
Rate comparison of complete recovery in stress pad test after 12 weeks of treatment
Complete recovery is defined as urinary leakage below than 2 gram in stress pad test.
Time frame: 12 weeks
Incontinence Severity VAS at baseline,4weeks,8weeks,12weeks after treatment
Time frame: 12 weeks
Sandvik questionnaire at baseline,4weeks,8weeks,12weeks after treatment
Time frame: 12 weeks
Incontinence - Quality of Life questionnaire at baseline,8weeks,12 weeks after treatment
Time frame: 12 weeks
Benefit,Satisfaction and Willingness to Continue questionnaire at 12 weeks after treatment
Time frame: 12 weeks
Pelvic floor muscular strength at baseline,4weeks,8weeks,12weeks after treatment
Intravaginal pressure, Extracorporeal pelvic floor muscular strength, Oxford Scale at baseline,4weeks,8weeks,12weeks after treatment
Time frame: 12 weeks
This study is completed, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Samsung Medical Center